Dark

RDHL
Redhill Biopharma Ltd.
stock NASDAQ ADR

At Close

Jun 18, 2025 3:59:30 PM EDT

1.84USD+4.147%(+0.07)10,895

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 16, 2025 9:17:30 AM EDT

1.75USD-0.947%(-0.02)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

4.22M

CEO

Dror Ben-Asher

Headquarters

21 Haarbaa St, Tel Aviv Yafo, Israel

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Aug 14, 2025 (55d)

Last Split

Aug 20, 20241for25reverse

GSK SNY MRK TARO TEVA XLV

RDHL Stats

Avg. Vol. 10 Day

21,728

Avg. Vol. 30 Day

151,064

Employees

113

Market Cap

4,216,459

Shares Out.

2,291,554

On/Off Exchange

56%/44%

6 Month Beta

1.12

1 Year Beta

0.75

2 Year Beta

0.55

3 Year Beta

0.67

52 Week Low

1.71

52 Week High

20.28

SMA50

2.04

SMA200

5.44

1 Week

-5.16%

1 Month

-3.16%

3 Month

-33.44%

6 Month

-71.56%

1 Year

-80.11%

2 Year

-95.98%

5 Year

-99.97%

Profile

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise

RDHL Stock Summary

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock price today is $1.84, and today's volume is 10,895. RDHL is up 4.147% today. The 30 day average volume is 151,064. RDHL market cap is 4.22M with 2,291,554 shares outstanding.